Ann Pediatr Endocrinol Metab.  2014 Jun;19(2):69-75. 10.6065/apem.2014.19.2.69.

Phthalate exposure and childhood obesity

• Kim SH
• Park MJ

• KMID: 1803856
• DOI: http://doi.org/10.6065/apem.2014.19.2.69

Abstract

Phthalates are commonly used as plasticizers and vehicles for cosmetic ingredients. Phthalate metabolites have documented biochemical activity including activating peroxisome proliferator-activated receptor and antiandrogenic effects, which may contribute to the development of obesity. In vitro and in vivo studies suggest that phthalates have significant effects on the development of obesity, especially after prenatal exposure at low doses. Although few studies have examined the effects of phthalate on obesity development in humans, some work has shown that phthalates affect humans and animals similarly. In this paper, we review the possible mechanisms of phthalate-induced obesity, and discuss evidence supporting the role of phthalates in the development of obesity in humans.

Keyword

Diethylhexyl phthalate; Child; Endocrine disruptors; Obesity

MeSH Terms

Animals
Child
Diethylhexyl Phthalate
Endocrine Disruptors
Humans
Obesity
Pediatric Obesity*
Peroxisomes
Plasticizers
Plastics
Diethylhexyl Phthalate
Endocrine Disruptors
Plasticizers
Plastics

Figure

• 

  Fig. 1 Metabolic pathways of phthalates.

Reference

1. Park YS, Lee DH, Choi JM, Kang YJ, Kim CH. Trend of obesity in school age children in Seoul over the past 23 years. Korean J Pediatr. 2004; 47:247–257.

2. Kim KE, Kim SH, Park S, Khang YH, Park MJ. Changes in prevalence of obesity and underweight among Korean children and adolescents: 1998-2008. Korean J Obes. 2012; 21:228–235.

3. Morris JN. Obesity in Britain: lifestyle data do not support sloth hypothesis. BMJ. 1995; 311:1568–1569. PMID: 8520410.

4. Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med. 2002; 8:185–192. PMID: 12006126.

5. Hauser R, Calafat AM. Phthalates and human health. Occup Environ Med. 2005; 62:806–818. PMID: 16234408.

6. Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal. 2006; 26:803–824. PMID: 16834635.

7. Calafat AM, McKee RH. Integrating biomonitoring exposure data into the risk assessment process: phthalates [diethyl phthalate and di(2-ethylhexyl) phthalate] as a case study. Environ Health Perspect. 2006; 114:1783–1789. PMID: 17107868.

8. Hauser R, Meeker JD, Park S, Silva MJ, Calafat AM. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect. 2004; 112:1734–1740. PMID: 15579421.

9. Teitelbaum SL, Britton JA, Calafat AM, Ye X, Silva MJ, Reidy JA, et al. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ Res. 2008; 106:257–269. PMID: 17976571.

10. Wittassek M, Angerer J. Phthalates: metabolism and exposure. Int J Androl. 2008; 31:131–138. PMID: 18070048.

11. Bekö G, Weschler CJ, Langer S, Callesen M, Toftum J, Clausen G. Children's phthalate intakes and resultant cumulative exposures estimated from urine compared with estimates from dust ingestion, inhalation and dermal absorption in their homes and daycare centers. PLoS One. 2013; 8:e62442. PMID: 23626820.

12. Grün F, Blumberg B. Endocrine disrupters as obesogens. Mol Cell Endocrinol. 2009; 304:19–29. PMID: 19433244.

13. Corton JC, Lapinskas PJ. Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract? Toxicol Sci. 2005; 83:4–17. PMID: 15496498.

14. Grygiel-Górniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review. Nutr J. 2014; 13:17. PMID: 24524207.

15. Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord. 2003; 27:147–161. PMID: 12586994.

16. Feige JN, Gerber A, Casals-Casas C, Yang Q, Winkler C, Bedu E, et al. The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms. Environ Health Perspect. 2010; 118:234–241. PMID: 20123618.

17. Hao C, Cheng X, Xia H, Ma X. The endocrine disruptor mono-(2-ethylhexyl) phthalate promotes adipocyte differentiation and induces obesity in mice. Biosci Rep. 2012; 32:619–629. PMID: 22953781.

18. Foster PM, Mylchreest E, Gaido KW, Sar M. Effects of phthalate esters on the developing reproductive tract of male rats. Hum Reprod Update. 2001; 7:231–235. PMID: 11392369.

19. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect. 2006; 114:270–276. PMID: 16451866.

20. Pan G, Hanaoka T, Yoshimura M, Zhang S, Wang P, Tsukino H, et al. Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China. Environ Health Perspect. 2006; 114:1643–1648. PMID: 17107847.

21. Lehrke M, Lazar MA. The many faces of PPARgamma. Cell. 2005; 123:993–999. PMID: 16360030.

22. Hurst CH, Waxman DJ. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci. 2003; 74:297–308. PMID: 12805656.

23. Bility MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, et al. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol Sci. 2004; 82:170–182. PMID: 15310864.

24. al-Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab. 1997; 82:1118–1125. PMID: 9100583.

25. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005; 90:4019–4024. PMID: 15870128.

26. Erkekoglu P, Giray BK, Kizilgun M, Hininger-Favier I, Rachidi W, Roussel AM, et al. Thyroidal effects of di-(2-ethylhexyl) phthalate in rats of different selenium status. J Environ Pathol Toxicol Oncol. 2012; 31:143–153. PMID: 23216639.

27. Wenzel A, Franz C, Breous E, Loos U. Modulation of iodide uptake by dialkyl phthalate plasticisers in FRTL-5 rat thyroid follicular cells. Mol Cell Endocrinol. 2005; 244:63–71. PMID: 16289305.

28. Meeker JD, Calafat AM, Hauser R. Di(2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels in men. Environ Health Perspect. 2007; 115:1029–1034. PMID: 17637918.

29. Meeker JD, Ferguson KK. Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U.S. adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007-2008. Environ Health Perspect. 2011; 119:1396–1402. PMID: 21749963.

30. Boas M, Frederiksen H, Feldt-Rasmussen U, Skakkebæk NE, Hegedus L, Hilsted L, et al. Childhood exposure to phthalates: associations with thyroid function, insulin-like growth factor I, and growth. Environ Health Perspect. 2010; 118:1458–1464. PMID: 20621847.

31. Wu MT, Wu CF, Chen BH, Chen EK, Chen YL, Shiea J, et al. Intake of phthalate-tainted foods alters thyroid functions in Taiwanese children. PLoS One. 2013; 8:e55005. PMID: 23383031.

32. Janesick A, Blumberg B. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today. 2011; 93:34–50. PMID: 21425440.

33. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med. 1976; 295:349–353. PMID: 934222.

34. Martorell R, Stein AD, Schroeder DG. Early nutrition and later adiposity. J Nutr. 2001; 131:874S–880S. PMID: 11238778.

35. Ong KK, Loos RJ. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatr. 2006; 95:904–908. PMID: 16882560.

36. Lamb JC 4th, Chapin RE, Teague J, Lawton AD, Reel JR. Reproductive effects of four phthalic acid esters in the mouse. Toxicol Appl Pharmacol. 1987; 88:255–269. PMID: 3564043.

37. Jarfelt K, Dalgaard M, Hass U, Borch J, Jacobsen H, Ladefoged O. Antiandrogenic effects in male rats perinatally exposed to a mixture of di(2-ethylhexyl) phthalate and di(2-ethylhexyl) adipate. Reprod Toxicol. 2005; 19:505–515. PMID: 15749265.

38. Meeker JD, Hu H, Cantonwine DE, Lamadrid-Figueroa H, Calafat AM, Ettinger AS, et al. Urinary phthalate metabolites in relation to preterm birth in Mexico city. Environ Health Perspect. 2009; 117:1587–1592. PMID: 20019910.

39. Zhang Y, Lin L, Cao Y, Chen B, Zheng L, Ge RS. Phthalate levels and low birth weight: a nested case-control study of Chinese newborns. J Pediatr. 2009; 155:500–504. PMID: 19555962.

40. Huang Y, Li J, Garcia JM, Lin H, Wang Y, Yan P, et al. Phthalate levels in cord blood are associated with preterm delivery and fetal growth parameters in Chinese women. PLoS One. 2014; 9:e87430. PMID: 24503621.

41. Wolff MS, Engel SM, Berkowitz GS, Ye X, Silva MJ, Zhu C, et al. Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect. 2008; 116:1092–1097. PMID: 18709157.

42. Suzuki Y, Niwa M, Yoshinaga J, Mizumoto Y, Serizawa S, Shiraishi H. Prenatal exposure to phthalate esters and PAHs and birth outcomes. Environ Int. 2010; 36:699–704. PMID: 20605637.

43. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect. 2007; 115:876–882. PMID: 17589594.

44. Hatch EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, Singer M, et al. Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health. 2008; 7:27. PMID: 18522739.

45. Trasande L, Attina TM, Sathyanarayana S, Spanier AJ, Blustein J. Race/ethnicity-specific associations of urinary phthalates with childhood body mass in a nationally representative sample. Environ Health Perspect. 2013; 121:501–506. PMID: 23428635.

46. Buser MC, Murray HE, Scinicariello F. Age and sex differences in childhood and adulthood obesity association with phthalates: Analyses of NHANES 2007-2010. Int J Hyg Environ Health. 2014; 3. 05. [Epub]. http://dx.doi.org/10.1016/j.ijheh.2014.02.005.

47. Lind PM, Roos V, Ronn M, Johansson L, Ahlstrom H, Kullberg J, et al. Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly women. Environ Health. 2012; 11:21. PMID: 22472124.

48. Teitelbaum SL, Mervish N, Moshier EL, Vangeepuram N, Galvez MP, Calafat AM, et al. Associations between phthalate metabolite urinary concentrations and body size measures in New York City children. Environ Res. 2012; 112:186–193. PMID: 22222007.